Abbott Laboratories

ISIN US0028241000 Symbol ABT Industry Medical Devices Sector Healthcare
Abbott Laboratories Price
111.7USD 0.78%
1y Low: 74.2
1y High: 128.5
1y Low: 74.2
1y High: 128.5
Abbott Laboratories Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
abbott.com
Market Cap
210.6 B USD
Dividend Yield
1.3%
Performance 1y
24.57 %
PER
47.5

Abbott Laboratories Stock Chart

Abbott Laboratories Dividend Chart

Abbott Laboratories Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 2 0.90 USD 1.6 %
2020 4 1.44 USD 1.3 %
2019 4 1.28 USD 1.5 %
2018 4 1.12 USD 1.6 %
2017 4 1.06 USD 2.0 %
2016 4 1.04 USD 2.9 %
2015 4 0.96 USD 2.4 %
2014 4 0.88 USD 2.2 %
2013 4 0.56 USD 1.7 %
2012 4 0.96 USD 3.6 %
2011 4 0.90 USD 4.2 %
2010 4 0.82 USD 4.6 %
2009 4 0.75 USD 3.7 %
2008 4 0.67 USD 3.6 %
2007 4 0.61 USD 3.1 %
2006 4 0.55 USD 3.4 %
2005 4 0.52 USD 3.9 %
2004 5 1.86 USD 12.5 %
2003 4 0.46 USD 3.3 %
2002 4 0.44 USD 4.1 %
2001 4 0.39 USD 2.5 %
2000 4 0.35 USD 2.6 %
1999 4 0.32 USD 3.1 %
1998 4 0.28 USD 2.2 %
1997 5 0.31 USD 3.6 %
1996 4 0.22 USD 3.3 %
1995 4 0.20 USD 3.8 %
1994 4 0.18 USD 4.5 %
1993 4 0.16 USD 4.4 %
1992 4 0.14 USD 3.8 %
1991 4 0.11 USD 3.0 %
1990 4 0.096 USD 3.8 %
1989 4 0.077 USD 4.4 %
1988 4 0.065 USD 5.2 %
1987 4 0.29 USD 24.0 %
1986 4 0.045 USD 4.1 %
1985 4 0.038 USD 4.9 %

Abbott Laboratories Performance

1 Week
1 Month
6.39 %
6 Months
2.83 %
Year to Date
1.59 %
1 Year
24.57 %
5 Years
226.8 %

Abbott Laboratories Revenue, EBIT, and Income

Abbott Laboratories Margins

Abbott Laboratories Shares Outstanding

Useful Links

Search Twitter: $ABT, #ABT

Abbott Laboratories Company Info

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.

Abbott Laboratories Headquarter

100 Abbott Park Road, 60064 North Chicago, IL, USA

Abbott Laboratories Price to Earnings Ratio (PE Ratio): 47.5

The current Price to Earnings Ratio of Abbott Laboratories is 47.5.
The PE Ratio is calcluated by dividing the current Abbott Laboratories share price (111.7 USD) by the earnings per share (2.5).

Abbott Laboratories Dividend Yield: 1.3%

The current Dividend Yield of Abbott Laboratories is 1.3%.

Abbott Laboratories Market Cap: 210.6 B USD

The current market cap of Abbott Laboratories is 210.6 B USD.

Abbott Laboratories Stock Price: 111.7 USD

The current stock price of Abbott Laboratories is 111.7 USD.

Abbott Laboratories ISIN: US0028241000

The ISIN (International Securities Identification Number) of Abbott Laboratories is US0028241000.

Abbott Laboratories Ticker Symbol: ABT

The ticker symbol of Abbott Laboratories is ABT.

Abbott Laboratories Address

The address of the Abbott Laboratories HQ is 100 Abbott Park Road, 60064 North Chicago, IL, USA.